Literature DB >> 28362681

Dual ovarian stimulation and random start in assisted reproductive technologies: from ovarian biology to clinical application.

Alberto Vaiarelli1, Roberta Venturella, Damiano Vizziello, Francesco Bulletti, Filippo M Ubaldi.   

Abstract

PURPOSE OF REVIEW: The opportunity to use gonadotropins to stimulate the growth of antral follicles coming from different follicular waves available in different moment of the menstrual cycle allowed the implementation of innovative protocols in assisted reproductive technologies. The purpose of this review is to explore the possible advantages related to these new controlled ovarian stimulation (COS) strategies. RECENT
FINDINGS: Women exhibit major and minor wave patterns of ovarian follicular development during the menstrual cycle, as it is in animal species. These observations led to the introduction of two new strategies for COS: the random start and the double ovarian stimulation within a single menstrual cycle.
SUMMARY: The use of gonadotropin-releasing hormone antagonist COS protocols, started randomly at any day of the menstrual cycle, is today a standard procedure in those cases where obtaining oocytes is an urgent task, such as in case of fertility preservation for malignant diseases or other medical indications.On the other hand, in poor prognosis patients, double ovarian stimulation has been suggested with the aim of maximizing the number of oocytes retrieved within a single menstrual cycle and, in turn increasing the chance to obtain a reproductively competent embryo. Randomized control trials are necessary to confirm these preliminary findings.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28362681     DOI: 10.1097/GCO.0000000000000365

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  9 in total

1.  Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles.

Authors:  Sfakianoudis Konstantinos; Tsioulou Petroula; Maziotis Evangelos; Giannelou Polina; Glava Argyro; Grigoriadis Sokratis; Rapani Anna; Nezos Andrianos; Pantou Agni; Koutsilieris Michael; Pantos Konstantinos; Mastorakos George; Simopoulou Mara
Journal:  J Assist Reprod Genet       Date:  2020-03-27       Impact factor: 3.412

2.  Development of a predictive model for luteal phase oocyte retrieval in poor responders undergoing natural cycle IVF.

Authors:  Mara Simopoulou; Dionysios Galatis; Evangelos Maziotis; Agni Pantou; Polina Giannelou; Sokratis Grigoriadis; Panagiotis Tzonis; Theodora Griva; Athanasios Zikopoulos; Anastasios Philippou; Michael Koutsilieris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

3.  Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.

Authors:  Danilo Cimadomo; Alberto Vaiarelli; Silvia Colamaria; Elisabetta Trabucco; Carlo Alviggi; Roberta Venturella; Erminia Alviggi; Ramona Carmelo; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Hum Reprod       Date:  2018-08-01       Impact factor: 6.918

Review 4.  Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Authors:  Filippo Maria Ubaldi; Danilo Cimadomo; Alberto Vaiarelli; Gemma Fabozzi; Roberta Venturella; Roberta Maggiulli; Rossella Mazzilli; Susanna Ferrero; Antonio Palagiano; Laura Rienzi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

5.  Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients.

Authors:  Camila Cruz de Moraes; Victoria Furquim Werneck Marinho; Ana Luísa Menezes Campos; Janaína de Souza Guedes; Érica Becker de Sousa Xavier; João Pedro Junqueira Caetano; Ricardo Mello Marinho
Journal:  JBRA Assist Reprod       Date:  2019-04-30

6.  Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues.

Authors:  So Yun Park; Kyungah Jeong; Eun Hye Cho; Hye Won Chung
Journal:  Clin Exp Reprod Med       Date:  2020-11-02

7.  Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Alessandro Conforti; Sandro C Esteves; Peter Humaidan; Salvatore Longobardi; Thomas D'Hooghe; Raoul Orvieto; Alberto Vaiarelli; Danilo Cimadomo; Laura Rienzi; Filippo Maria Ubaldi; Fulvio Zullo; Carlo Alviggi
Journal:  Reprod Biol Endocrinol       Date:  2021-06-21       Impact factor: 5.211

8.  Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Elisabetta Trabucco; Roberta Vallefuoco; Laura Buffo; Ludovica Dusi; Fabrizio Fiorini; Nicoletta Barnocchi; Francesco Maria Bulletti; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-14       Impact factor: 5.555

9.  DuoStim - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Cecilia Petriglia; Alessandro Conforti; Carlo Alviggi; Nicolò Ubaldi; Sergio Ledda; Susanna Ferrero; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Ups J Med Sci       Date:  2020-04-25       Impact factor: 2.384

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.